Related Experiment Video
Updated: Sep 19, 2025
A Matrigel-Based Tube Formation Assay to Assess the Vasculogenic Activity of Tumor Cells
Published on: September 7, 2011
Vascular mimicry developments in non-small cell lung cancer
Xiaoyou Zhong1, Yiteng Gao1, Jiajia Lv1
1Department of Hematology and Oncology, Geriatric Hospital of Nanjing Medical University, Nanjing, 210024, China.
Abstract:
Non-small cell lung cancer (NSCLC) remains a prevalent and lethal malignancy worldwide, posing significant challenges in therapeutic management. The limited clinical effectiveness of conventional antiangiogenic therapies in NSCLC is mainly attributed to vasculogenic mimicry (VM), an atypical angiogenic mechanism observed in tumors. VM involves tumor cells transforming into vascular-like channels, advancing tumor progression by providing essential nutrients and oxygen. These structures, formed by tumor cells instead of endothelial cells, are resistant to traditional antiangiogenic drugs targeting vascular endothelial growth factor (VEGF) pathways, allowing tumors to evade suppression by standard antivascular treatments and significantly contributing to therapeutic resistance. Therefore, a thorough investigation of VM formation mechanisms, its regulatory pathways, and the association between VM formation mechanisms and prognosis in NSCLC has both theoretical and clinical significance for developing innovative therapeutic strategies and improving patient survival.
Insights
Vasculogenic mimicry (VM) in non-small cell lung cancer (NSCLC) allows tumor cells to form vascular channels, causing resistance to antiangiogenic therapies. Understanding VM is crucial for developing new NSCLC treatments.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment
Background:
- Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related death globally.
- Conventional antiangiogenic therapies often show limited efficacy in NSCLC.
- Vasculogenic mimicry (VM), a process where tumor cells form vascular-like channels, contributes to therapeutic resistance.
Purpose of the Study:
- To investigate the mechanisms of VM formation in NSCLC.
- To explore the regulatory pathways involved in VM.
- To determine the association between VM and prognosis in NSCLC patients.
Main Methods:
- Detailed analysis of VM formation in NSCLC models.
- Identification of key molecular pathways regulating VM.
- Correlation studies between VM presence and patient outcomes.
Main Results:
- Tumor cells, not endothelial cells, form VM channels in NSCLC.
- VM structures provide nutrients and oxygen, promoting tumor progression.
- VM formation is linked to resistance against vascular endothelial growth factor (VEGF) targeted therapies.
Conclusions:
- VM is a significant factor in NSCLC therapeutic resistance.
- Targeting VM pathways may offer novel treatment strategies for NSCLC.
- Further research into VM mechanisms is vital for improving patient survival in NSCLC.
